Drug-induced thrombotic microangiopathy: An updated review of causative drugs, pathophysiology, and management

Drug-induced thrombotic microangiopathy (DITMA) represents 10%–13% of all thrombotic microangiopathy (TMA) cases and about 20%–30% of secondary TMAs, just behind pregnancy-related and infection-related forms. Although the list of drugs potentially involved as causative for TMA are rapidly increasing...

Descripció completa

Dades bibliogràfiques

Autors principals:	Tommaso Mazzierli, Federica Allegretta, Enrico Maffini, Marco Allinovi
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2023-01-01
Col·lecció:	Frontiers in Pharmacology
Matèries:	thrombotic microangiopathy hemolytic-uremic syndrome thrombotic thrombocytopenic purpura drug-induced toxicity nephrotoxicity
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fphar.2022.1088031/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!